Rare cutaneous side-effect of gefitinib masquerading as superficial dermatophytosis

Clinical and Experimental Dermatology

Volumn 34, Issue 4, 2009, Pages 528-530

  Lin, S S ^a   Tsai, T H ^b   Yang, H H ^b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUOCINONIDE; GEFITINIB; SHAMPOO; TAR;

ADULT; CASE REPORT; DERMATOMYCOSIS; DIAGNOSTIC ERROR; DRUG INDUCED DISEASE; ERYTHEMA; FEMALE; HAIR LOSS; HISTOPATHOLOGY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LYMPHOCYTIC INFILTRATION; MICROBIOLOGY; PARONYCHIA; PRIORITY JOURNAL; RASH; SCALP PRURITUS; SKIN BIOPSY; SKIN SWELLING; SKIN TOXICITY; STAINING; TINEA CRURIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DERMATOMYCOSES; DRUG ERUPTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PERINEUM; QUINAZOLINES; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 65649150054     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02978.x     Document Type: Letter

References (4)

1. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003 12 : 2787 99. (Pubitemid 46606324)
2. Links Hu JC, Sadeghi P, Pinter-Brown LC et al. Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J Am Acad Dermatol 2007 56 : 317 26. (Pubitemid 46091817)
3. Agero AL, Dusza SW, Benvenuto-Andrade C et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006 55 : 657 70. (Pubitemid 44436627)
4. Graves JE, Jones BF, Lind AC et al. Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. J Am Acad Dermatol 2006 55 : 349 53. (Pubitemid 44038007)